M&M to invest Rs 1500 crore in Nasik, Igatpuri plants and top corporate news of the day

India Infoline News Service | Mumbai | February 13, 2017 09:17 IST

Tablet computer with business news
Aurobindo Pharma was looking to set up a manufacturing facility for injectable products in the United States, days after President Donald Trump called on pharmaceutical companies to make more drugs locally. (BL)
Dr Reddy's Laboratories Ltd has announced the expansion of its commercial operations in Europe with the introduction of its portfolio of generics in France. (BS)
Mahindra & Mahindra plans to invest Rs15bn in its Nashik and Igatpuri facility in the state of Maharashtra to prepare for the introduction of new project "U321". (ET)
Tata Chemicals (TCL) is setting up two facilities in Andhra Pradesh and Gujarat to manufacture soluble dietary fibres and silica with an investment of Rs5.65bn. (BS)
The Delhi High Court recently refused to provide Sun Pharmaceuticals any interim relief in their trademark infringement case against rival drug manufacturer Mylan Laboratories for the production of the cancer medication Oxaliplatin. (BS)
ITC Ltd is looking to enter healthcare segment and set up multi-speciality hospitals. (BL)
Oil and Natural Gas Corp's (ONGC's) USD2.475bn purchase of Videocon Group's 10% stake in a Mozambique gas field has come under the Oil Ministry's scanner following allegations that the public sector unit (PSU) might have overpaid about USD200mn, charges that the company denied. (BS)
CESC Ltd is awarded the electricity distribution franchise for Bikaner in Rajasthan through competitive bidding. (BL)